Clinical Trial Update: A Real-World Study of Pirtobrutinib in cBTKi-Resistant/Intolerant Mature B-Cell Lymphoma

View source ↗

Summary

A real-world study evaluating pirtobrutinib in mature B-cell lymphoma patients who are resistant or intolerant to covalent BTK inhibitors; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mature B-cell Lymphoma

Drugs mentioned

• Pirtobrutinib (pirtobrutinib)

Snippet

Sponsor: Ou Bai, MD/PHD | Conditions: Mature B-Cell Lymphoma | Status: NOT_YET_RECRUITING